151
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
Condition(s):Hemophilia ALast Updated:February 1, 2018Completed
Factor VIII: 881 Clinical Trials, Page 16 of 89
Hide Studies Not Open or Pending
152
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII
Condition(s):Hemophilia ALast Updated:July 27, 2012Completed
153
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
Condition(s):Hemophilia ALast Updated:May 14, 2021Terminated
154
VALIDATE: Factor VIII Trending for MS Relapse
Condition(s):Multiple SclerosisLast Updated:September 21, 2021Withdrawn
155
A Study of FVIII Gene Therapy for Hemophilia A
Condition(s):Hemophilia ALast Updated:July 12, 2022Not yet recruiting
156
BAX 802 in CHA With Inhibitors
Condition(s):Hemophilia ALast Updated:October 20, 2021Terminated
157
Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With Hemophilia
Condition(s):Hemophilia ALast Updated:May 15, 2020Unknown status
158
A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate
Condition(s):Hemophilia ALast Updated:January 18, 2023Active, not recruiting
159
Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A
Condition(s):Severe Hemophilia ALast Updated:September 11, 2017Completed
160
Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A
Condition(s):Prophylaxis; Hemophilia ALast Updated:February 13, 2015Completed